Clinical Trials and Research

(asked on 17th May 2018) - View Source

Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, whether he has made an economic assessment of the (a) value of early-phase research and (b) inward investment generated by early-phase trials.


Answered by
Sam Gyimah Portrait
Sam Gyimah
This question was answered on 22nd May 2018

The Industrial Strategy White Paper sets out the central role of science and innovation in meeting the UK’s productivity challenge. The UK economy gets a high rate of return for our investment in Science – 20% per annum in perpetuity. The UK research base is highly productive in terms of article and citation outputs per researcher and per pound spend on R&D. With only 0.9% of the global population, 4.1% of researchers, the UK accounts for 6.3% of research articles, 10.7% of citations and 15.2% of the most highly-cited research articles. The UK draws in proportionally more internationally mobile investment in Research & Development than other large countries. For further information: http://oecd.org/sti/msti

Reticulating Splines